Immunohistochemical Expression of CK20, p53, and Ki-67 as Objective Markers of Urothelial Dysplasia

This publication has 22 references indexed in Scilit:

• Discriminatory Immunohistochemical Staining of Urothelial Carcinoma in Situ and Non-neoplastic Urothelium
  The American Journal of Surgical Pathology, 2001
• Comparison of the WHO/ISUP Classification and Cytokeratin 20 Expression in Predicting the Behavior of Low-Grade Papillary Urothelial Tumors
  Laboratory Investigation, 2001
• Tumor Markers in the Detection of Recurrent Transitional Cell Carcinoma of the Bladder
  Acta Cytologica, 2001
• Relationship of Cytokeratin 20 and CD44 Protein Expression with WHO/ISUP Grade in pTa and pT1 Papillary Urothelial Neoplasia
  Laboratory Investigation, 2000
• Intraepithelial Lesions of Urinary Bladder: Morphologic Considerations
  Scandinavian Journal of Urology and Nephrology, 2000
• Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases
  Laboratory Investigation, 2000
• The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder
  The American Journal of Surgical Pathology, 1998
• Prognostic value of Ki-67 antigen and p53 protein in urinary bladder cancer: immunohistochemical analysis of radical cystectomy specimens
  BJU International, 1997
• Cytokeratin 20 as an objective marker of urothelial dysplasia
  British Journal of Urology, 1996
• Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody
  Histopathology, 1994